查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988768

2026年全球生物分析檢測服務市場報告

Bioanalytical Testing Services Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，生物分析檢測服務市場發展迅速。預計該市場規模將從2025年的37.3億美元成長至2026年的41.1億美元，複合年成長率（CAGR）為10.4%。過去幾年的成長主要歸功於製藥業研發活動的擴大、臨床藥物檢測支援需求的增加、對合約檢測實驗室依賴性的提高、監管合規要求的日益嚴格以及分析技術基礎設施的快速發展。

預計未來幾年生物分析檢測服務市場將快速成長，到2030年將達到62.7億美元，複合年成長率（CAGR）為11.1%。預測期內的成長主要歸功於生技藥品和生物相似藥的快速發展、全球臨床試驗的活性化、對精確藥物動力學評估的日益重視、個人化醫療的不斷推進以及對檢驗治療方法安全性的日益重視。預測期內的關鍵趨勢包括：對藥物評估準確性的需求不斷成長、對分析物可靠定量分析的日益重視、生物分析檢測外包業務的增加、對監管標準合規性的日益重視以及專業生物檢體分析的日益普及。

各國主導加強遏制感染疾病疫情，顯著推動了生物分析檢測服務市場的成長。新冠肺炎疫情更是刺激了對生物分析檢測服務的需求。世界各國都在採取各種措施，並增加支出，以防止感染疾病的傳播和影響。例如，根據美國公共研究機構國會研究服務處（CRS）2023年3月發布的報告，美國國立衛生研究院（NIH）下屬的國家過敏症和感染疾病研究所（NIAID）的經費從2023年的63.23億美元增加到65.62億美元。因此，各國政府加強遏制感染疾病疫情正在推動生物分析檢測服務市場的發展。

生物分析檢測服務市場的主要企業正致力於推出先進的解決方案，例如逆轉錄聚合酶鍊式反應 (RT-PCR) 檢測，以鞏固其市場地位。逆轉錄聚合酶鍊式反應 (RT-PCR) 檢測是一種實驗室技術，它利用一種名為逆轉錄酶的酵素將 RNA 轉化為互補 DNA (cDNA)。例如，2023 年 6 月，總部位於法國的檢測實驗室 Eurofins Scientific SE 推出了 NovaType SARS-CoV-2 RT-PCR 檢測。 NovaType SARS-CoV-2 RT-PCR 檢測已通過臨床檢驗，且由於其快速反應時間，適用於對數百萬個陽性檢體進行複測，以確定病毒是否為特定變異株。這是一種即時逆轉錄聚合酶鍊式聚合酵素鏈鎖反應(RT-PCR) 檢測，旨在定性檢測導致 COVID-19 的病毒 SARS-CoV-2，並識別特定變異株，例如 B.1.1.7 和 B.1.351。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球生物分析檢測服務市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因體學、精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 對藥物評價準確性的要求日益提高。
    • 人們對可靠的分析物定量分析越來越感興趣。
    • 生物分析測試外包業務的擴張
    • 越來越重視遵守監理標準
    • 專業生物檢體分析技術的應用日益廣泛

第5章 終端用戶產業市場分析

  • 製藥公司
  • 生物製藥製造商
  • 合約研究組織（CTA）
  • 受託製造廠商)
  • 臨床研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球生物分析檢測服務市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球生物分析檢測服務市場規模、對比及成長率分析
  • 全球生物分析檢測服務市場表現：規模與成長，2020-2025年
  • 全球生物分析檢測服務市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按測試類型
  • ADME（吸收、分佈、代謝、排泄）、藥物動力學、動態、生物等效性、生物利用度
  • 依分子類型
  • 低分子化合物，高分子化合物
  • 最終用戶
  • 製藥和生物製藥公司、合約開發和生產組織（CDMO）以及受託研究機構（CRO）
  • 依類型細分：ADME（吸收、分佈、代謝、排泄）
  • 吸收試驗、分佈試驗、代謝試驗、排泄試驗
  • 按類型細分：藥物動力學
  • Cmax（最大濃度）、Tmax（達到 Cmax 的時間）、AUC（曲線下面積）、半衰期測試。
  • 按類型細分：動態
  • 療效研究、安全性研究、劑量反應研究
  • 按類型細分：生物等效性
  • 體外生物等效性試驗
  • 按類型細分：生物利用度
  • 絕對生物有效性測試、相對生物有效性測試

第10章 區域與國別分析

  • 全球生物分析檢測服務市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年、2035年
  • 全球生物分析檢測服務市場：依國家分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 生物分析檢測服務市場：競爭格局及市場佔有率（2024年）
  • 生物分析檢測服務市場：公司估值矩陣
  • 生物分析檢測服務市場：公司概況
    • CD BioSciences
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Laboratory Corporation of America Holdings（LabCorp）
    • Eurofins Scientific SE

第37章 其他大型企業和創新企業

  • ICON plc, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年生物分析檢測服務市場：提供新機會的國家
  • 2030年生物分析檢測服務市場：新興細分市場機會
  • 2030年生物分析檢測服務市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: SE5MBTSE02_G26Q1

Bioanalytical testing services encompass cutting-edge methodologies for quantifying analytes. These services play a pivotal role in identifying and characterizing pharmaceuticals and metabolites within biological fluids such as blood, plasma, serum, urine, or tissue extracts.

Bioanalytical testing services encompass various essential tests, including ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic, pharmacodynamic, bioequivalence, and bioavailability assessments. ADME examines how a chemical undergoes absorption, distribution, metabolism, and excretion within a living organism, crucial for understanding drug processing. It aids in evaluating safety, toxicity, and the viability of drugs, offering precise targets for future research and development endeavors. These testing services analyze both small and large molecules, catering to pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, as well as contract research organizations. They serve as indispensable tools in drug development and assessment, providing vital insights into a compound's behavior within biological systems.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the bioanalytical testing services market by increasing the cost of laboratory instruments, analytical devices, reagents, and specialized testing equipment sourced internationally, which raises overall service delivery expenses. Segments such as pharmacokinetic testing, pharmacodynamic analysis, bioequivalence studies, and ADME testing are particularly affected, especially across key pharmaceutical hubs in North America, Europe, and Asia Pacific. However, tariffs are also encouraging localized analytical infrastructure development and strengthening regional testing capabilities. Overall, tariffs create short term cost challenges while supporting long term regional resilience and technological advancement in bioanalytical testing services.

The bioanalytical testing services market research report is one of a series of new reports from The Business Research Company that provides bioanalytical testing services market statistics, including bioanalytical testing services industry global market size, regional shares, competitors with a bioanalytical testing services market share, detailed bioanalytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the bioanalytical testing services industry. This bioanalytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioanalytical testing services market size has grown rapidly in recent years. It will grow from $3.73 billion in 2025 to $4.11 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to growth in pharmaceutical r&d activities, rising demand for clinical drug testing support, increasing reliance on contract testing organizations, expansion of regulatory compliance needs, early development of analytical technology infrastructure.

The bioanalytical testing services market size is expected to see rapid growth in the next few years. It will grow to $6.27 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising biologics and biosimilar development, increasing clinical trial intensity worldwide, growing focus on precise pharmacokinetic assessment, expansion of personalized medicine initiatives, stronger emphasis on safe therapeutic validation. Major trends in the forecast period include increasing demand for drug assessment accuracy, rising focus on reliable quantification of analytes, growing expansion of outsourced bioanalytical testing, strengthening emphasis on regulatory standard compliance, increasing adoption of specialized biological sample analysis.

The rising government initiative to control infectious disease outbreaks is significantly contributing to the growth of the bioanalytical testing services market. The outbreak of the COVID-19 pandemic has aided in the growth in demand for bioanalytical testing services. Countries worldwide have been taking initiatives and increasing spending to prevent the spread and impact of the diseases. For instance, in March 2023, according to a report published by the Congressional Research Service, a US-based public policy research institute. The funding from National Institutes of Health (NIH) for Allergy/Infectious Diseases (NIAID) has increased from $6,323 million to $6,562 in 2023. Therefore, the rising government initiatives to control infectious disease outbreaks is driving the bioanalytical testing services market.

Major companies operating in the bioanalytical testing services market are focused on introducing advanced solutions, such as reverse transcription PCR (RT-PCR) tests, to sustain their position in the market. The reverse transcription PCR (RT-PCR) test is a laboratory technique that involves the conversion of RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. For instance, in June 2023, Eurofins Scientific SE, a France-based testing laboratory company, launched the NovaType SARS-CoV-2 RT-PCR assay. The NovaType SARS-CoV-2 RT-PCR assay is clinically validated and has a short turnaround time, which is suitable for re-testing millions of positive samples to detect if the virus is a specific variant. It is a real-time reverse transcription PCR (RT-PCR) test designed for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19, and the subsequent identification of specific variants, such as B.1.1.7 and B.1.351.

In August 2023, Scantox AB, a Denmark-based provider of bioanalytical and toxicology services, acquired Q&Q Labs AB for an undisclosed sum. Through this acquisition, Scantox AB seeks to enhance its bioanalytical service portfolio and broaden its capabilities in supporting drug development and safety evaluation. Q&Q Labs AB is a Sweden-based company that offers bioanalytical testing services, including pharmacokinetic, immunogenicity, and biomarker analyses for pharmaceutical and biotechnology firms.

Major companies operating in the bioanalytical testing services market report are CD BioSciences, Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, ICON plc, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc., Toxikon Inc., Absorption Systems LLC, Lotus Labs Pvt. Ltd., Bioneeds India Private Limited, Vipragen Biosciences Pvt. Ltd., Source BioScience

North America was the largest region in the bioanalytical testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioanalytical testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioanalytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bioanalytical testing services market includes revenues earned by entities by providing services such as method development, high throughput sample analysis, method validation, and pharmacokinetic and toxicokinetic support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioanalytical Testing Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bioanalytical testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioanalytical testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioanalytical testing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: ADME (Absorption, Distribution, Metabolism, And Excretion); Pharmacokinetic; Pharmacodynamic; Bioequivalence; Bioavailability
  • 2) By Molecule Type: Small Molecules; Large Molecules
  • 3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Contract Research Organizations
  • Subsegments:
  • 1) By ADME (Absorption, Distribution, Metabolism, and Excretion): Absorption Studies; Distribution Studies; Metabolism Studies; Excretion Studies
  • 2) By Pharmacokinetic: Cmax (Maximum Concentration); Tmax (Time To Reach Cmax); AUC (Area Under the Curve); Half-Life Studies
  • 3) By Pharmacodynamic: Efficacy Testing; Safety Testing; Dose-Response Relationship Studies
  • 4) By Bioequivalence: In Vivo Bioequivalence Studies; In Vitro Bioequivalence Studies
  • 5) By Bioavailability: Absolute Bioavailability Studies; Relative Bioavailability Studies
  • Companies Mentioned: CD BioSciences; Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; ICON plc; PPD Inc.; SGS SA; WuXi AppTec; Syneos Health Inc.; Charles River Laboratories Inc.; Intertek Group; Covance Inc.; PAREXEL International Corporation; Medpace Holdings Inc.; Almac Group; Pace Analytical Services LLC; Altasciences; BioAgilytix Labs; Frontage Laboratories Inc.; Toxikon Inc.; Absorption Systems LLC; Lotus Labs Pvt. Ltd.; Bioneeds India Private Limited; Vipragen Biosciences Pvt. Ltd.; Source BioScience
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Bioanalytical Testing Services Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Bioanalytical Testing Services Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Bioanalytical Testing Services Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Bioanalytical Testing Services Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Demand For Drug Assessment Accuracy
    • 4.2.2 Rising Focus On Reliable Quantification Of Analytes
    • 4.2.3 Growing Expansion Of Outsourced Bioanalytical Testing
    • 4.2.4 Strengthening Emphasis On Regulatory Standard Compliance
    • 4.2.5 Increasing Adoption Of Specialized Biological Sample Analysis

5. Bioanalytical Testing Services Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biopharmaceutical Manufacturers
  • 5.3 Contract Research Organizations
  • 5.4 Contract Development And Manufacturing Organizations
  • 5.5 Clinical Research Institutions

6. Bioanalytical Testing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bioanalytical Testing Services Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Bioanalytical Testing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Bioanalytical Testing Services Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Bioanalytical Testing Services Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Bioanalytical Testing Services Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bioanalytical Testing Services Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bioanalytical Testing Services Market Segmentation

  • 9.1. Global Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • ADME (Absorption, Distribution, Metabolism, And Excretion), Pharmacokinetic, Pharmacodynamic, Bioequivalence, Bioavailability
  • 9.2. Global Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Small Molecules, Large Molecules
  • 9.3. Global Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biopharmaceutical Companies, Contract Development And Manufacturing Organizations, Contract Research Organizations
  • 9.4. Global Bioanalytical Testing Services Market, Sub-Segmentation Of ADME (Absorption, Distribution, Metabolism, And Excretion), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Absorption Studies, Distribution Studies, Metabolism Studies, Excretion Studies
  • 9.5. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Pharmacokinetic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cmax (Maximum Concentration), Tmax (Time To Reach Cmax), AUC (Area Under the Curve), Half-Life Studies
  • 9.6. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Pharmacodynamic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Efficacy Testing, Safety Testing, Dose-Response Relationship Studies
  • 9.7. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Bioequivalence, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Bioequivalence Studies, In Vitro Bioequivalence Studies
  • 9.8. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Bioavailability, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Absolute Bioavailability Studies, Relative Bioavailability Studies

10. Bioanalytical Testing Services Market Regional And Country Analysis

  • 10.1. Global Bioanalytical Testing Services Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Bioanalytical Testing Services Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bioanalytical Testing Services Market

  • 11.1. Asia-Pacific Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bioanalytical Testing Services Market

  • 12.1. China Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bioanalytical Testing Services Market

  • 13.1. India Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bioanalytical Testing Services Market

  • 14.1. Japan Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bioanalytical Testing Services Market

  • 15.1. Australia Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bioanalytical Testing Services Market

  • 16.1. Indonesia Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bioanalytical Testing Services Market

  • 17.1. South Korea Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bioanalytical Testing Services Market

  • 18.1. Taiwan Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bioanalytical Testing Services Market

  • 19.1. South East Asia Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bioanalytical Testing Services Market

  • 20.1. Western Europe Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bioanalytical Testing Services Market

  • 21.1. UK Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bioanalytical Testing Services Market

  • 22.1. Germany Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bioanalytical Testing Services Market

  • 23.1. France Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bioanalytical Testing Services Market

  • 24.1. Italy Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bioanalytical Testing Services Market

  • 25.1. Spain Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bioanalytical Testing Services Market

  • 26.1. Eastern Europe Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bioanalytical Testing Services Market

  • 27.1. Russia Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bioanalytical Testing Services Market

  • 28.1. North America Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bioanalytical Testing Services Market

  • 29.1. USA Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bioanalytical Testing Services Market

  • 30.1. Canada Bioanalytical Testing Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bioanalytical Testing Services Market

  • 31.1. South America Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bioanalytical Testing Services Market

  • 32.1. Brazil Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bioanalytical Testing Services Market

  • 33.1. Middle East Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bioanalytical Testing Services Market

  • 34.1. Africa Bioanalytical Testing Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Bioanalytical Testing Services Market, Segmentation By Test Type, Segmentation By Molecule Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bioanalytical Testing Services Market Regulatory and Investment Landscape

36. Bioanalytical Testing Services Market Competitive Landscape And Company Profiles

  • 36.1. Bioanalytical Testing Services Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Bioanalytical Testing Services Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Bioanalytical Testing Services Market Company Profiles
    • 36.3.1. CD BioSciences Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Bioanalytical Testing Services Market Other Major And Innovative Companies

  • ICON plc, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc.

38. Global Bioanalytical Testing Services Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bioanalytical Testing Services Market

40. Bioanalytical Testing Services Market High Potential Countries, Segments and Strategies

  • 40.1 Bioanalytical Testing Services Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Bioanalytical Testing Services Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Bioanalytical Testing Services Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer